Biopsies from short segments of columnar appearing mucosa in the distal esophagus often fail to reveal intestinal metaplasia (IM). The yield of IM on repeat upper endoscopy (EGD) and biopsy in these patients is not known. Our aim was to prospectively evaluate the yield of IM on repeat EGD in patients with suspected SSBE (negative for IM on first EGD). Forty-three patients with suspected SSBE underwent repeat EGD with biopsy. This included 42 men and 1 woman, mean age 53 years (range: 45-90) with a mean columnar mucosa length of 1.26 cm (range: 0.5-2.5). On repeat EGD, 10 of 43 patients (23.2%) had evidence of IM. There was no statistically significant difference between the patients with proven SSBE on repeat EGD compared to those with persistent negative IM with regards to age, ethnicity, length of columnar mucosa, GERD symptoms, and hiatal hernia size. In conclusion, more than 20% of patients with suspected SSBE have evidence of IM (ie, proven SSBE) on repeat EGD. Thus repeat EGD with biopsy may be warranted in patients with tongues of columnar mucosa in the distal esophagus but no IM on the first biopsy to confirm the diagnosis of SSBE.

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1019697501650DOI Listing

Publication Analysis

Top Keywords

repeat egd
24
patients suspected
16
ssbe repeat
12
egd biopsy
12
suspected ssbe
12
columnar mucosa
12
intestinal metaplasia
8
patients
8
repeat
8
mucosa distal
8

Similar Publications

Beneath the Surface: Diagnosing Gastric Linitis Plastica.

J Community Hosp Intern Med Perspect

November 2024

MedStar Health Internal Medicine Residency Program, Baltimore, MD, USA.

Gastric Linitis plastica is characterized by extensive infiltration of gastric wall by poorly differentiated tumor cells, creating a "leather-bottle stomach" appearance. We describe a case involving a 71-year-old male presenting with globus sensation, early satiety and weight loss. Recent EGD had revealed chronic gastritis with polypoid mucosa at the GE junction, and subsequent FDG-PET indicated asymmetric FDG localization.

View Article and Find Full Text PDF

Acute esophageal necrosis (AEN) is an uncommon endoscopic finding characterized by a patchy or diffuse circumferential black pigmentation of the esophageal mucosa, corresponding to ischemic necrosis. It usually presents with upper gastrointestinal bleeding and is thought to be caused by a systemic low blood flow in patients with predisposing risk factors, like advanced age and cardiovascular comorbidities. After initial hemodynamic stabilization, diagnosis is established by esophagogastroduodenoscopy (EGD) with careful biopsies and histological evaluation.

View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous T-cell lymphomas (CTCL) are the most common type of primary skin lymphoma, primarily affecting the skin but also showing extracutaneous symptoms.
  • Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphoma (pcAECTCL) is a rare, aggressive subtype with poor outcomes and potential for systemic spread, particularly to organs like the lungs and central nervous system.
  • A case study is presented of a patient with a persistent rash diagnosed with pcAECTCL, where imaging showed possible gastric involvement, but no definitive evidence of metastasis was found after further examination.
View Article and Find Full Text PDF

Pancreatic cysts are abnormal masses found in the pancreas. They are either cancerous or benign and are mostly found incidentally on imaging. The majority are asymptomatic, but these cysts can sometimes become so large that they obstruct the function of structures around them.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the endoscopic outcomes in adults without diabetes who are on glucagon-like peptide receptor agonists (GLP-1 RAs) compared to those not using these medications.
  • Researchers analyzed data from a group of adults with a BMI of 27 or higher who underwent diagnostic esophagogastroduodenoscopy (EGD) to determine any significant differences in outcomes.
  • The results showed no significant difference in the rates of repeat EGD or new diagnoses of gastroparesis between those taking GLP-1 RAs and those who were not, suggesting that these medications may not greatly increase the risk for these outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!